Brandname is Bexsero and apparently it has not been approved by the FDA/CDC for the US market but because of the outbreaks in princeton and on the west coast (were it is not being used) an exemption was made so students now are receiving these shots. It has been approved for use in Europe though.
Doing research on some other topic, I came across this from the UK:
There it is not recommended as a routine vax due to cost-effectiveness, lack of efficacy rates and fast waning antibodies plus an increase in fever cases if added to the regular baby vaccine schedule.
The German Vaccine Commission is not recommending it either: http://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2013/Ausgaben/49_13.pdf?__blob=publicationFile
Also based on the above plus side effects that need to be determined further especially the incidents on Kawasaki Syndrome.
The vaccine has been tested in a small group of only 5,000 infants and 2,500 youth/adults so far.
“The only true wisdom is in knowing you know nothing.”
There are trials going on here (Canada) to try to get meningitis B vaccine licensed. I wonder if there are trials going on in the US too.